Physician profile

Noel Camba

Cardiovascular Disease · Palos Park, IL

NPI 1083668560

$129,738.84

in general payments reported to CMS, 2019-2025

42 companies · $2,416 in 2025

The $2,416 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$16,768.00
Food and Beverage$8,310.76
Education$198.95

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $69,013.10 2019-2024 Xarelto
Esperion Therapeutics, INC. $19,247.60 2020-2025 Nexletol
Chiesi USA, INC. $15,025.24 2019-2025 Kengreal, Cleviprex
Novartis Pharmaceuticals Corporation $8,154.09 2019-2025
Astrazeneca Pharmaceuticals LP $7,626.30 2019-2025 Farxiga, Lokelma, Wainua
Medtronic, INC. $1,188.89 2021-2025 Corevalve Evolut R, Micra, Aurora Ev-Icd Mri Surescan
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $988.37 2019-2025 Lifevest
Pfizer INC. $878.86 2019-2025
Merck Sharp & Dohme LLC $766.87 2021-2025 Verquvo, Capvaxive, Winrevair
Amgen INC. $762.12 2019-2025 Repatha, Repatha
Boston Scientific Corporation $754.13 2019-2025 General - Therapies, Bodyguardian, Lux-Dx Insertable Cardiac Monitor
Bayer Healthcare Pharmaceuticals INC. $557.86 2020-2025
Boehringer Ingelheim Pharmaceuticals, INC. $551.58 2019-2025 Jardiance
Preventric Diagnostics, INC. $464.50 2021
Actelion Pharmaceuticals US, INC. $360.61 2019-2024 Uptravi, Opsumit
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Amarin Pharma, INC. $347.37 2019-2021
Novo Nordisk INC $277.12 2024-2025 Wegovy, Ozempic, Rybelsus
Elutia, INC. $228.87 2022-2025 Ecm Patch,Pouch
Kowa Pharmaceuticals America, INC. $225.69 2019-2024 Livalo
E.R. Squibb & Sons, L.L.C. $220.86 2019-2025 Camzyos, Eliquis
Sanofi-Aventis U.S. LLC $191.78 2019-2024
Alnylam Pharmaceuticals INC. $184.56 2019-2025 Onpattro, Amvuttra
Medtronic Vascular, INC. $178.16 2019
Shockwave Medical, INC $176.11 2022
Cardiovascular Systems INC. $175.45 2019-2023 Diamondback Coronary
Jenavalve Technology, INC. $162.44 2022
Edwards Lifesciences Corporation $131.58 2019-2025 Sapien 3 Ultra Resilia
Abiomed $126.31 2023 Impella
Abbott Laboratories $115.52 2022-2024 Cardiomems, Diamondback Peripheral, Jeti Peripheral Catheter
Regeneron Healthcare Solutions, INC. $111.76 2019
Scpharmaceuticals INC. $103.38 2023-2025
Lexicon Pharmaceuticals, INC. $95.30 2023-2024 Inpefa
Kestra Medical Technology Services, INC. $80.18 2023-2025 Assure Wcd
Allergan, INC. $54.56 2019
Portola Pharmaceuticals, LLC $46.75 2019
Livanova USA, INC. $37.28 2022
Inspire Medical Systems, INC. $35.31 2024 Inspire
Idorsia Pharmaceuticals US INC $23.25 2025 Tryvio
Teleflex LLC $21.08 2023 Guideliner
Kiniksa Pharmaceuticals International, Plc $20.16 2024 Arcalyst
Akcea Therapeutics, INC. $16.52 2020
Philips North America LLC $11.37 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Noel Camba

$129,738.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Janssen Pharmaceuticals, INC
Context
The $2,416 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/94416/noel-camba

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.